✦ LIBER ✦

Using biologic markers to optimize therapies

✍ Scribed by Wendy L. Allen; Patrick G. Johnston

Book ID: 107535603
Publisher: Current Science Inc.
Year: 2005
Tongue: English
Weight: 304 KB
Volume: 1
Category: Article
ISSN: 1556-3790
DOI: 10.1007/s11888-005-0012-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Unraveling molecular markers of biologic

Unraveling molecular markers of biologic therapies in glioma

✍ Andrew B. Lassman; Lauren E. Abrey 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 65 KB

Biologic therapeutics and molecular prof

Biologic therapeutics and molecular profiling to optimize wound healing

✍ Marie N. Menke; Nathan B. Menke; Cecelia H. Boardman; Robert F. Diegelmann 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 245 KB

Development of resistance to biologic th

Development of resistance to biologic therapies with reference to IFN-

✍ Farrell, R. A.; Marta, M.; Gaeguta, A. J.; Souslova, V.; Giovannoni, G.; Creeke, 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 262 KB

Predictors of response to biologic thera

Predictors of response to biologic therapies in rheumatoid arthritis

✍ Lara M. Chaves Chaparro; Juan Salvatierra Ossorio; Enrique Raya Álvarez 📂 Article 📅 2011 🏛 Elsevier Science 🌐 Spanish ⚖ 257 KB

Biological markers: Potential biomarker

Biological markers: Potential biomarker for aspirin use in colorectal cancer therapy

✍ Langley, Ruth E.; Rothwell, Peter M. 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 155 KB

Using CFdesign to optimize performance

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 531 KB

A new CFdesign module, which facilitates carrying out multi-scenario design studies, has allowed Cornell Pump to spend more time on pump design, and much less time on expensive rework. CFD allows reliable simulation and optimization of the design, placement and performance of critical components, as